Inhibition of platelet aggregation by aspirin in vitro varies considerably between healthy subjects

被引：0
|
作者：
Goodman, Timothy [1 ]
Sharma, Pankaj [2 ]
Ferro, Albert [1 ]
机构：
[1] Kings Coll London, London WC2R 2LS, England
[2] Univ London Imperial Coll Sci Technol & Med, London, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：988 / 988
页数：1
相关论文
共 50 条
  • [1] Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects
    Jakubowski, Joseph A.
    Payne, Christopher D.
    Weerakkody, Govinda J.
    Brandt, John T.
    Farid, Nagy A.
    Li, Ying G.
    Naganuma, Hideo
    Lachno, D. Richard
    Winters, Kenneth J.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (03) : 167 - 173
  • [2] Population Pharmacodynamic Modelling of Aspirin- and Ibuprofen-Induced Inhibition of Platelet Aggregation in Healthy Subjects
    Ying Hong
    Fran M. Gengo
    Michelle M. Rainka
    Vernice E. Bates
    Donald E. Mager
    [J]. Clinical Pharmacokinetics, 2008, 47 : 129 - 137
  • [3] Population pharmacodynamic modelling of aspirin- and ibuprofen-induced inhibition of platelet aggregation in healthy subjects
    Hong, Ying
    Gengo, Fran M.
    Rainka, Michelle M.
    Bates, Vernice E.
    Mager, Donald E.
    [J]. CLINICAL PHARMACOKINETICS, 2008, 47 (02) : 129 - 137
  • [4] ASPIRIN INHIBITION OF PLATELET-AGGREGATION
    COLANDO, K
    [J]. AMERICAN JOURNAL OF MEDICAL TECHNOLOGY, 1979, 45 (05): : 448 - 448
  • [5] INHIBITION OF PLATELET-AGGREGATION BY ASPIRIN INVITRO
    BOCHNER, F
    SILS, D
    RODGERS, SE
    LLOYD, JV
    [J]. ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 50 - 50
  • [6] Platelet Aggregation Inhibitory Effects and Pharmacokinetics of Prasugrel Used in Combination With Aspirin in Healthy Japanese Subjects
    Umemura, Kazuo
    Ikeda, Yasuhiko
    Matsushima, Nobuko
    Kondo, Kazunao
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (04): : 398 - 407
  • [7] Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects
    Kraft, W. K.
    Gilmartin, J. H.
    Chappell, D. L.
    Gheyas, F.
    Walker, B. M.
    Nagalla, S.
    Naik, U. P.
    Horrow, J. C.
    Wrishko, R. E.
    Zhang, S.
    Anderson, M. S.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2016, 9 (04): : 221 - 227
  • [8] Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers
    Karha, Juhana
    Rajagopal, Vivek
    Kottke-Marchant, Kandice
    Bhatt, Deepak L.
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (05) : 976.e7 - 976.e11
  • [9] POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF EPTIFIBATIDE IN THE INHIBITION OF PLATELET AGGREGATION IN HEALTHY CHINESE SUBJECTS
    Li, Qinmei
    Zhang, Hong
    Wu, Min
    Liu, Jingrui
    Li, Cuiyun
    Ding, Yanhua
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S83 - S84
  • [10] Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects
    Liu, Li
    Ding, Yanhua
    Jiao, Zheng
    Wu, Min
    Li, Cuiyun
    Liu, Jingrui
    Liu, Chengjiao
    Hu, Yue
    Li, Qingmei
    Zhang, Hong
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (02): : 267 - 276
12345